

NCT02601157 comparison:

Summary:
CHIA has 2 criteria while your personal folder has 2 criteria
Total found criteria: 2/2
Total not Found: 0/2
Total Extra: 0
This trial is VALID



╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╕
│ CHIA Criteria                                     │ Matching Personal Criteria                        │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╡
│ Patients with de novo stenotic lesions who are    │ Patients with de novo stenotic lesions who are    │
│ suitable for coronary stenting with drug-eluting  │ suitable for coronary stenting with drug-eluting  │
│ stent                                             │ stent                                             │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ High risk profiles for ischemic adverse events    │ High risk profiles for ischemic adverse events    │
│ such as A. ST-segment elevation myocardial        │ such as A. ST-segment elevation myocardial        │
│ infarction (STEMI) B. Patients with cardiogenic   │ infarction (STEMI) B. Patients with cardiogenic   │
│ shock or concomitant severe decompensated heart   │ shock or concomitant severe decompensated heart   │
│ failure C. Myocardial infarction or stent         │ failure C. Myocardial infarction or stent         │
│ thrombosis in spite of the maintenance of         │ thrombosis in spite of the maintenance of         │
│ antiplatelet therapy D. Restenosis in stented     │ antiplatelet therapy D. Restenosis in stented     │
│ segments or previous sites of balloon angioplasty │ segments or previous sites of balloon angioplasty │
│ 2. Patients who cannot follow allocated DAPT      │ 2. Patients who cannot follow allocated DAPT      │
│ schedule due to the planned surgery or elective   │ schedule due to the planned surgery or elective   │
│ procedure within 3 months after the stenting 3.   │ procedure within 3 months after the stenting 3.   │
│ Recent history of major surgery or evident events │ Recent history of major surgery or evident events │
│ of gastrointestinal bleeding within 1 month from  │ of gastrointestinal bleeding within 1 month from  │
│ the procedure 4. Patients on anticoagulation      │ the procedure 4. Patients on anticoagulation      │
│ therapy with warfarin or other anticoagulants 5.  │ therapy with warfarin or other anticoagulants 5.  │
│ Life expectancy less than 1 year (such as         │ Life expectancy less than 1 year (such as         │
│ malignancies or other chronic systemic diseases)  │ malignancies or other chronic systemic diseases)  │
│ 6. Pregnant women 7. Past history of allergy or   │ 6. Pregnant women 7. Past history of allergy or   │
│ other contraindications for the following         │ other contraindications for the following         │
│ medications/materials: aspirin, clopidogrel,      │ medications/materials: aspirin, clopidogrel,      │
│ heparin, cobalt chromium, sirolimus               │ heparin, cobalt chromium, sirolimus               │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╛



Everything was Found



We had Nothing Extra